celecoxib has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TC; Chow, RH; Farley, RA; Kardosh, A; Liu, YT; Louie, SG; Mircheff, AK; Petasis, NA; Pyrko, P; Schönthal, AH; Soriano, N; Uddin, J; Xiong, W | 1 |
| Bae, JH; Ha, GH; Kang, CD; Kim, GR; Kim, SH; Kim, SJ; Oh, SO; Park, YS; Son, CH; Yang, K | 1 |
2 other study(ies) available for celecoxib and thapsigargin
| Article | Year |
|---|---|
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Caspases, Initiator; Celecoxib; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Cytoplasm; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Humans; Mice; Mice, Nude; Molecular Chaperones; Protein Biosynthesis; Pyrazoles; Sulfonamides; Thapsigargin; Transcription Factor CHOP | 2007 |
COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells.
Topics: AC133 Antigen; Antigens, CD; Celecoxib; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytotoxicity, Immunologic; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Glycoproteins; GPI-Linked Proteins; HT29 Cells; Humans; Hyaluronan Receptors; Intracellular Signaling Peptides and Proteins; Killer Cells, Natural; Peptides; Pyrazoles; Receptors, TNF-Related Apoptosis-Inducing Ligand; Sulfonamides; Thapsigargin; Transcription Factor CHOP | 2015 |